Spyre Therapeutics Inc (SYRE)

EBITDA Margin

0.00%

Quarterly · Period ending:

SYRE logo

SYRE EBITDA Margin

Latest reported0.00%
SYRE Quarterly EBITDA Margin (0.00% → 0.00%)
High-resolution chart · PNG

SYRE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
0%
0%
-69.0985%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-4,119.7674%
-9,045.4545%
-10,951.7857%
-10,310.9195%
-3,494.24%
-1,764.5374%
-549.1767%
-1,420.2287%
-46.2909%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-403.4903%
-541.3907%
-442.6451%
-628.7867%
-450.169%
-639.4094%
-441.6199%
-545.4308%
-397.815%
-528.2887%
-250.347%
-316.123%
-41.2606%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.